This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/APGE/capital-change-brief"
Use Arkolith's capital_change_brief for APGE. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | Withheld | 10.3M | ▲+277% Added · +7.6M sh | Q1 2026 | |
| 2 | FMR LLC | $779.6M | 9.3M | ▲+13% Added · +1.0M sh | Q1 2026 | |
| 3 | Venrock Adviser, LLC | $714.9M | 8.5M | —Held | Q1 2026 | |
| 4 | BlackRock, Inc. | $343.9M | 4.1M | ▲+8.0% Added · +302K sh | Q1 2026 | |
| 5 | RTW INVESTMENTS, LP | $234.2M | 2.8M | ▲+2.6% Added · +70K sh | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $210.6M | 2.5M | ▲New +2.5M sh | Q1 2026 | |
| 7 | JANUS HENDERSON GROUP PLC | $198.8M | 2.4M | ▲+14% Added · +298K sh | Q1 2026 | |
| 8 | STATE STREET CORP | $182.1M | 2.2M | ▲+28% Added · +473K sh | Q1 2026 | |
| 9 | PERCEPTIVE ADVISORS LLC | $129.7M | 1.5M | ▼−34% Reduced · −790K sh | Q1 2026 | |
| 10 | Paradigm Biocapital Advisors LP | $113.5M | 1.3M | ▲+20% Added · +225K sh | Q1 2026 | |
| 11 | Affinity Asset Advisors, LLC | $108.2M | 1.3M | ▲+4.0% Added · +50K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $102.5M | 1.2M | ▲+15% Added · +158K sh | Q1 2026 | |
| 13 | UBS Group AG | $96.3M | 1.1M | ▲+17% Added · +170K sh | Q1 2026 | |
| 14 | PRICE T ROWE ASSOCIATES INC /MD/ | $96.2M | 1.1M | ▼−7.6% Reduced · −94K sh | Q1 2026 | |
| 15 | JPMORGAN CHASE & CO | $87.4M | 1.1M | ▼−19% Reduced · −263K sh | Q1 2026 | |
| 16 | Vestal Point Capital, LP | $92.6M | 1.1M | ▲+100% Added · +550K sh | Q1 2026 | |
| 17 | FRONTIER CAPITAL MANAGEMENT CO LLC | $89.6M | 1.1M | ▲+122% Added · +584K sh | Q1 2026 | |
| 18 | ALLIANCEBERNSTEIN L.P. | $74.7M | 990K | ▼−9.4% Reduced · −103K sh | Q1 2026 | |
| 19 | BANK OF AMERICA CORP /DE/ | $75.8M | 901K | ▲+14% Added · +107K sh | Q1 2026 | |
| 20 | MERCER GLOBAL ADVISORS INC /ADV | $70.0M | 831K | ▼−6.7% Reduced · −59K sh | Q1 2026 | |
| 21 | GOLDMAN SACHS GROUP INC | $54.9M | 653K | ▲+15% Added · +87K sh | Q1 2026 | |
| 22 | CITADEL ADVISORS LLC | $50.4M | 599K | ▼−22% Reduced · −168K sh | Q1 2026 | |
| 23 | MORGAN STANLEY | $50.1M | 595K | ▼−33% Reduced · −295K sh | Q1 2026 | |
| 24 | JENNISON ASSOCIATES LLC | $49.2M | 585K | ▲+1.1% Added · +6K sh | Q1 2026 | |
| 25 | Remedium Capital Partners, LLC | $49.1M | 584K | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | Dambkowski Carl | Chief Medical Officer | Gift (G) | 8K | $0 |
| Jul 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Gift (G) | 75K | $0 |
| Jul 8, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 20K | $2.7M |
| Jul 1, 2026 | Dambkowski Carl | Chief Medical Officer | Option exercise (M) | 4K | $0 |
| Jul 1, 2026 | Dambkowski Carl | Chief Medical Officer | Sell (S) | 6K | $730K |
| Jul 1, 2026 | Dambkowski Carl | Chief Medical Officer | Option exercise (M) | 4K | $94K |
| Jun 22, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 80K | $10.6M |
| Jun 22, 2026 | Dambkowski Carl | Chief Medical Officer | Sell (S) | 26K | $3.5M |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 7K | $557K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 8K | $634K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 1K | $91K |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell (S) | 2K | $134K |
| Company | Co-held by | Combined value |
|---|---|---|
| BOSTON SCIENTIFIC CORPBSX | 63 funds | $2.1B |
| ADVANCED MICRO DEVICESAMD | 62 funds | $5.3B |
| INTUITIVE SURGICAL INCISRG | 62 funds | $3.3B |
| NVIDIA CORPNVDA | 61 funds | $51.1B |
| MICROSOFT CORPMSFT | 61 funds | $32.2B |
| AMAZON.COM INCAMZN | 61 funds | $27.3B |
| ELI LILLY & COLLY | 61 funds | $8.8B |
| META PLATFORMS INC-CLASS AMETA | 60 funds | $15.4B |
| ALPHABET INC-CL AGOOGL | 59 funds | $21.9B |
| BROADCOM INCAVGO | 59 funds | $18.5B |
| MICRON TECHNOLOGY INCMU | 59 funds | $8.6B |
| CHEVRON CORPCVX | 59 funds | $3.9B |
Ranked by how many of APGE's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for APGE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.